Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

3ÁÖ·É ÈòÁã¿¡¼­ µð¿¡Ä¥´ÏÆ®·Î»ç¹Î Åõ¿©¿¡ ÀÇÇÑ GST-P+ fociÀÇ À¯µµ: GST-P+ foci¸¦ ÀÌ¿ëÇÑ »õ·Î¿î Á߱⠰£ ¹ß¾Ï ½ÇÇè¹ýÀÇ ½Ãµµ Development of GST-P+ Foci in 3 Week Old Rats Induced by Ditthylnitrosamine: Preliminary data for liver foci model

´ëÇѾÏÇÐȸÁö 1994³â 26±Ç 2È£ p.231 ~ 235
¼Ò¼Ó »ó¼¼Á¤º¸
ÀåÀÚÁØ ÀÌÀ±½Ç/À̹̼÷/±èÅÂȯ

Abstract


A new medium-term in vivo hepatocarcinogenesis model was tried using GST-P+ hepatic foci. The treatment protocol was the i. p. injection of 50mg/kg body weight of diethylnitrosamine(DEN) once, twice or three times per week with or without 0.05%
phenobarbital(PB) in 3 week female Sprague-Dawley rats or male Fischer 344 rats. After 9 weeks, the rats were sacrificed and their livers were examined for immunohistochemically detectable GST-P+ foci. DEN treatment in 3 week old rats without PB
was
enough to induce GST-P+ foci. Protocol is very simple and convenient compared to other liver foci model using newborn rats or combined partial hepatectomy. And the yield of GST-P+ foci treated with DEN and PB was almost equal as other models.
Therefore,
this simple hepatic foci model may be useful for screening of carcinogenic or anticarcinogenic agents. For the validity of new model, more extensive studies will be necessary.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS